Helloworld Travel Ltd (HLO)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 1.370 |
|---|---|
| 52-week range | 1.298 – 1.977 |
| Return, 1 month / 3 months | −2.5% / −4.7% |
| Return, 1 year / 3 years | −15.9% / −24.8% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 29.4% |
| Worst drawdown (1 year) | -32.7% |
| Average daily value traded | 0.24M AUD |
| Dividend yield | 7.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Helloworld Travel is an Australian travel company that operates retail travel agency networks and wholesale travel distribution businesses. It serves leisure and corporate customers through franchised and company-owned agencies, offering bookings for air travel, cruises, accommodation and holiday packages. The company also provides support services to its agency members and distributes travel products to the trade. It is based in Australia and works with travellers and travel agents across its home market and beyond.
On this site Helloworld Travel Ltd appears as a stock on the Australian Securities Exchange (Australia), code HLO, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Helloworld Travel Ltd (HLO) trades on the Australian Securities Exchange in Australia. It last closed at AUD 1.370 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 499 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.9% and over the last three months it fell 4.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -8.8% | ||
| From 52-week high | -29.7% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.7% | ||
| 6-month return | -6.6% | ||
| 12-month return, skipping the last month | -13.7% | ||
| Risk (lower is better) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 29.4% | ||
| Worst drawdown (1 year) | -32.7% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.24M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.3% | ||
| Years with dividends | 5 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | −2.5% |
| 3 months | −4.7% |
| 6 months | −6.6% |
| 1 year | −15.9% |
| 3 years | −24.8% |
| 5 years | −34.3% |
Signals
| 50-day / 200-day average | 1.436 / 1.502 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.029 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2026 | AUD 0.0500 |
| 2 Mar 2026 | AUD 0.0500 |
| 1 Sep 2025 | AUD 0.0600 |
| 11 Mar 2025 | AUD 0.0800 |
| 5 Sep 2024 | AUD 0.0600 |
| 7 Mar 2024 | AUD 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.